A Multiple Dose Study of MK-3614 (MK-3614-002)

NCT01033643 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: MK-3614
DRUG: Placebo for MK-3614

Sponsor

Merck Sharp & Dohme LLC